Drue consumption and risks of polypharmacotherany in elderly population;Spotřeba léčiv v seniorské populaci a rizika polyfarmakoterapie ve stáří

Casopis Lekaru Ceskych

Volumn 145, Issue 9, 2006, Pages 708-711

  Kubesova H ^a,c   Holik J ^a   Weber, P ^a   Polcarova V ^a   Matejovsky J ^b   Mazalova K ^a   Slapak J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b RatiopharmCZ   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

Elderly population; Freely obtainable drugs; Herbal drugs; Polymorbidity; Polypragmasia

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN; NON PRESCRIPTION DRUG;

AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIET SUPPLEMENTATION; DRUG COST; DRUG USE; ELDERLY CARE; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; CZECH REPUBLIC; DRUG UTILIZATION; POLYPHARMACY; STATISTICS;

AGED; CZECH REPUBLIC; DRUG UTILIZATION; DRUGS, NON-PRESCRIPTION; FEMALE; HUMANS; MALE; POLYPHARMACY; PRESCRIPTIONS, DRUG;

EID: 33749129149     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kubešová, H., Holík, J., Šipr, K., Bogrová, I.: Farmakoterapie starších klientů praktického lékaře - teorie a skutečnost. Geriatria, 2000, VI, s. 27-32.
2. Glintborg, B., Andersen, S. E., Dalhoff, K.: Drug-drug interactions among hospitalized patiens - frequent but mostly clinically insignificant. Eur. J. Clin. Phrarmacol., 2005, 61, s. 675-681.
3. Atella, V., Schafheutle, E., Noyce, P. et al.: Affordability of medicines and patiens cost-reducing behaviour: Empirical evidence based on SUR Estimates from Italy and UK. Appl. Health Econ. Policy, 2005, 4, s. 23-25.
4. Riley-Doucet, C. K., Fouladbakhsh, J. M., Vallerand, A. H.: Canadian and Američan self treatment of pain: a comparison study. Rural. Repote Health, 2004, 4, s. 286.
5. Ehrlich, G. E.: A benefit/risk assessment of therapeutic alternatives for the treatment of painful inflammatory conditions. Int. J. Clin. Pract., 2004, 144 (Suppl.), s. 20-26.
6. Aira, M., Hartikainen, S., Sulkava, R.: Community prevalence of alcohol use and concomitant use of medication - a source of possible risk in the elderly aged 75 and older? Int. J. Geriatr. Psychiatry, 2005, 20, s. 680-685.
7. Barre, E., Bisseux, L., Chiasmu, F. et al.: Drug interactions in elderly population. Prospective assessment of their frequency and seriousness among 56 patients. Presse Med., 2005, 34, s. 837-841.
8. Topinková, E., Neuwirt, J.: Geriatrie pro praktického lékaře. Praha, Grada Publishing s.r.o., 1995, 299 s.
9. Nielsen, M. W., Hansen, E. H., Rasmussen, N. K.: Use of natural medicines in the danish population: a national cross-sectional survey. Ann. Pharmacother., 2005, 39, s. 1534-1538.
10. Colson, C. R., de Broe, M. E.: Kidney injury from alternative medicines. Adv. Chronic. Kidney Dis., 2005, 12, s. 261-275.
11. Kapusta, M., Dušek, J.: Terapeutické a toxické aspekty biologické aktivity Lubovníka bodkovaného (Hypericum perforatum). Čes. slov. Farm., 2003, 52, s. 20-28.
12. Henderson, L., Yue, Q. Y., Gerden, B. et al.: St John's Wort (Hypericum perforatum): drug interaction and clinical outcomes. Br. J. Clin. Pharmacol., 2002, 54, s. 349-356.